Internal Medicine, Interventional Cardiology · Kansas City, MO
NPI
1427012574
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1000 Carondelet Dr Ste 201b
Kansas City, MO, 64114
Phone (913) 956-2250
Groups this clinician bills Medicare through
Medicare paid, 2024
$228K
5,824 services
Medicare patients, 2024
1,514
Average age 77
Drug cost, 2024
$2.3M
16,492 prescriptions
Company payments, 2025
$22K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gerald M Mancuso was code 99214 (office e&m - established), 1,512 times for 1,113 patients. In total Gerald M Mancuso billed 5,824 services in 53 codes, and Medicare paid $228K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 1,512 | 1,113 | $63.16 | $95K |
| 93010 Electrocardiogram | Facility | 1,412 | 1,086 | $5.33 | $7,526 |
| 93351 Echocardiography (TTE/TEE) | Facility | 495 | 491 | $50.18 | $25K |
| 93325 Echocardiography (TTE/TEE) | Facility | 360 | 358 | $1.95 | $702 |
| 93306 Echocardiography (TTE/TEE) | Facility | 298 | 286 | $47.22 | $14K |
| 99232 Hospital E&M - Subsequent | Facility | 293 | 96 | $58.97 | $17K |
| 93294 External Electrocardiographic Monitoring | Facility | 209 | 76 | $19.23 | $4,020 |
| 93297 External Electrocardiographic Monitoring | Facility | 167 | 25 | $18.29 | $3,055 |
| 93018 Electrocardiogram | Facility | 102 | 100 | $9.74 | $993 |
| 99222 Hospital E&M - Initial | Facility | 91 | 81 | $91.38 | $8,315 |
| 85610 Clinical Chemistry | Office | 84 | 15 | $4.20 | $353 |
| 93280 External Electrocardiographic Monitoring | Facility | 76 | 58 | $23.63 | $1,796 |
| 99204 Office E&M - New | Facility | 73 | 73 | $84.15 | $6,143 |
| 93298 External Electrocardiographic Monitoring | Facility | 72 | 12 | $16.78 | $1,209 |
| 93016 Electrocardiogram | Facility | 68 | 68 | $15.36 | $1,045 |
By year: 2022 $276K for 5,584 services; 2023 $267K for 5,653 services; 2024 $228K for 5,824 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 84 | 15 | $4.20 | $353 |
Medicare prescription drug claims, 2024
In 2024, the drug Gerald M Mancuso prescribed most often to Medicare patients was Rosuvastatin Calcium, with 2,020 prescriptions and refills. In total Gerald M Mancuso wrote 16,492 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 2,020 | 5,708 | 619 | $23K |
| Atorvastatin Calcium Generic | 1,424 | 4,075 | 421 | $14K |
| Ezetimibe Generic | 1,309 | 3,746 | 390 | $28K |
| Metoprolol Succinate Generic | 1,242 | 3,551 | 395 | $14K |
| Olmesartan Medoxomil Generic | 1,214 | 3,481 | 369 | $24K |
| Nebivolol Hcl Generic | 988 | 2,572 | 314 | $62K |
| Amlodipine Besylate Generic | 911 | 2,564 | 289 | $6,482 |
| Xarelto Rivaroxaban | 693 | 1,472 | 187 | $809K |
| Torsemide Generic | 627 | 1,678 | 216 | $11K |
| Losartan Potassium Generic | 609 | 1,730 | 198 | $5,153 |
| Clopidogrel Clopidogrel Bisulfate | 566 | 1,546 | 170 | $7,444 |
| Eliquis Apixaban | 447 | 912 | 115 | $522K |
| Spironolactone Generic | 339 | 939 | 111 | $3,319 |
| Olmesartan-Hydrochlorothiazide Olmesartan/Hydrochlorothiazide | 283 | 828 | 94 | $12K |
| Repatha Sureclick Evolocumab | 242 | 488 | 58 | $282K |
Brand drugs: - claims; generic drugs: 14,624 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gerald M Mancuso $22K ($22K in general payments such as food, travel and fees) from 24 companies. The largest payer was Amgen Inc. with $8,983.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 25 | $8,983 |
| Lilly USA, LLC LLY | 13 | $8,551 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $2,617 |
| Novartis Pharmaceuticals Corporation NVS | 34 | $410 |
| Boston Scientific Corporation BSX | 10 | $319 |
| Alnylam Pharmaceuticals Inc. ALNY | 5 | $215 |
| Pfizer Inc. PFE | 9 | $161 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $155 |
| BridgeBio Pharma, Inc. BBIO | 7 | $144 |
| Novo Nordisk Inc NVO | 7 | $131 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.